AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Novick, D Schwartsburd, B Pinkus, R Suissa, D Belzer, I Sthoeger, Z Keane, WF Chvatchko, Y Kim, SH Fantuzzi, G Dinarello, CA Rubinstein, M
Citation: D. Novick et al., A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensivedecrease of free IL-18, CYTOKINE, 14(6), 2001, pp. 334-342

Authors: Kim, SHM Azam, T Yoon, DY Reznikov, LL Novick, D Rubinstein, M Dinarello, CA
Citation: Shm. Kim et al., Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein, P NAS US, 98(6), 2001, pp. 3304-3309

Authors: Stuyt, RJL Netea, MG Kim, SH Novick, D Rubinstein, M Kullberg, BJ Van der Meer, JWM Dinarello, CA
Citation: Rjl. Stuyt et al., Differential roles of interleukin-18 (IL-18) and IL-12 for induction of gamma interferon by staphylococcal cell wall components and superantigens, INFEC IMMUN, 69(8), 2001, pp. 5025-5030

Authors: Novick, D Nabioullin, RR Ragsdale, W McKenna, S Weiser, W Garone, L Burkins, C Kim, SH Rubinstein, M Tepper, MA Arulanandam, ARN
Citation: D. Novick et al., The neutralization of type IIFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation, J INTERF CY, 20(11), 2000, pp. 971-982

Authors: Banks, RE Forbes, MA Patel, PM Storr, M Hallam, S Clarke, D Novick, D Ingham, E Bowmer, C Southgate, J Trejdosiewicz, LK Illingworth, J Perren, TJ Selby, PJ
Citation: Re. Banks et al., Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: Pharmacokinetics, pharmacodynamics and immunomodulatory effects, CYTOKINE, 12(4), 2000, pp. 388-396

Authors: Liu, BL Novick, D Kim, SH Rubinstein, M
Citation: Bl. Liu et al., Production of a biologically active human interleukin 18 requires its prior synthesis as pro-IL-18, CYTOKINE, 12(10), 2000, pp. 1519-1525

Authors: Reznikov, LL Kim, SH Westcott, JY Frishman, J Fantuzzi, G Novick, D Rubinstein, M Dinarello, CA
Citation: Ll. Reznikov et al., IL-18 binding protein increases spontaneous and IL-1-induced prostaglandinproduction via inhibition of IFN-gamma, P NAS US, 97(5), 2000, pp. 2174-2179

Authors: Kim, SH Eisenstein, M Reznikov, L Fantuzzi, G Novick, D Rubinstein, M Dinarello, CA
Citation: Sh. Kim et al., Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18, P NAS US, 97(3), 2000, pp. 1190-1195

Authors: Vidal-Vanaclocha, F Fantuzzi, G Mendoza, L Fuentes, AM Anasagasti, MJ Martin, J Carrascal, T Walsh, P Reznikov, LL Kim, SH Novick, D Rubinstein, M Dinarello, CA
Citation: F. Vidal-vanaclocha et al., IL-18 regulates IL-1 beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1, P NAS US, 97(2), 2000, pp. 734-739

Authors: Haicheur, N Escudier, B Dorval, T Negrier, S De Mulder, PHM Dupuy, JM Novick, D Guillot, T Wolf, S Pouillart, P Fridman, WH Tartour, E
Citation: N. Haicheur et al., Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients, CLIN EXP IM, 119(1), 2000, pp. 28-37

Authors: Novick, D Kim, SH Fantuzzi, G Reznikov, LL Dinarello, CA Rubinstein, M
Citation: D. Novick et al., Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response, IMMUNITY, 10(1), 1999, pp. 127-136

Authors: Jones, SA Novick, D Horiuchi, S Yamamoto, N Szalai, AJ Fuller, GM
Citation: Sa. Jones et al., C-reactive protein: A physiological activator of interleukin 6 receptor shedding, J EXP MED, 189(3), 1999, pp. 599-604
Risultati: 1-12 |